These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 18696101)

  • 1. Extracellular matrix of the central nervous system: from neglect to challenge.
    Zimmermann DR; Dours-Zimmermann MT
    Histochem Cell Biol; 2008 Oct; 130(4):635-53. PubMed ID: 18696101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.
    Moon LD; Asher RA; Fawcett JW
    J Neurosci Res; 2003 Jan; 71(1):23-37. PubMed ID: 12478611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition.
    Jones LL; Sajed D; Tuszynski MH
    J Neurosci; 2003 Oct; 23(28):9276-88. PubMed ID: 14561854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans.
    Niederöst BP; Zimmermann DR; Schwab ME; Bandtlow CE
    J Neurosci; 1999 Oct; 19(20):8979-89. PubMed ID: 10516316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of aggrecan and versican in the developing rat central nervous system.
    Popp S; Andersen JS; Maurel P; Margolis RU
    Dev Dyn; 2003 May; 227(1):143-9. PubMed ID: 12701107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R.
    Brückner G; Grosche J; Schmidt S; Härtig W; Margolis RU; Delpech B; Seidenbecher CI; Czaniera R; Schachner M
    J Comp Neurol; 2000 Dec; 428(4):616-29. PubMed ID: 11077416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin sulfate proteoglycans: Key modulators in the developing and pathologic central nervous system.
    Dyck SM; Karimi-Abdolrezaee S
    Exp Neurol; 2015 Jul; 269():169-87. PubMed ID: 25900055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury.
    Jones LL; Margolis RU; Tuszynski MH
    Exp Neurol; 2003 Aug; 182(2):399-411. PubMed ID: 12895450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
    Stephenson EL; Mishra MK; Moussienko D; Laflamme N; Rivest S; Ling CC; Yong VW
    Brain; 2018 Apr; 141(4):1094-1110. PubMed ID: 29506186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin sulfate proteoglycans: key modulators of neuronal plasticity, long-term memory, neurodegenerative, and psychiatric disorders.
    Yang X
    Rev Neurosci; 2020 Jul; 31(5):555-568. PubMed ID: 32126020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of nervous tissue: developmental changes of neurocan and phosphacan.
    Meyer-Puttlitz B; Milev P; Junker E; Zimmer I; Margolis RU; Margolis RK
    J Neurochem; 1995 Nov; 65(5):2327-37. PubMed ID: 7595522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteoglycans in retina.
    Inatani M; Tanihara H
    Prog Retin Eye Res; 2002 Sep; 21(5):429-47. PubMed ID: 12207944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of chondroitin sulfate proteoglycans induces sprouting of intact purkinje axons in the cerebellum of the adult rat.
    Corvetti L; Rossi F
    J Neurosci; 2005 Aug; 25(31):7150-8. PubMed ID: 16079397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Chondroitin Sulfate Proteoglycans: An Emerging Therapeutic Strategy to Treat CNS Injury.
    Mukherjee N; Nandi S; Garg S; Ghosh S; Ghosh S; Samat R; Ghosh S
    ACS Chem Neurosci; 2020 Feb; 11(3):231-232. PubMed ID: 31939650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural variation of chondroitin sulfate and its roles in the central nervous system.
    Maeda N
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):22-31. PubMed ID: 20236040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican.
    Milev P; Maurel P; Chiba A; Mevissen M; Popp S; Yamaguchi Y; Margolis RK; Margolis RU
    Biochem Biophys Res Commun; 1998 Jun; 247(2):207-12. PubMed ID: 9642104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience-dependent development of perineuronal nets and chondroitin sulfate proteoglycan receptors in mouse visual cortex.
    Ye Q; Miao QL
    Matrix Biol; 2013 Aug; 32(6):352-63. PubMed ID: 23597636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding.
    Margolis RU; Margolis RK
    Cell Tissue Res; 1997 Nov; 290(2):343-8. PubMed ID: 9321696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perineuronal and perisynaptic extracellular matrix in the human spinal cord.
    Jäger C; Lendvai D; Seeger G; Brückner G; Matthews RT; Arendt T; Alpár A; Morawski M
    Neuroscience; 2013 May; 238():168-84. PubMed ID: 23428622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis.
    Sobel RA; Ahmed AS
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1198-207. PubMed ID: 11764092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.